Clinical Trials Logo

Pregnancy Toxemias clinical trials

View clinical trials related to Pregnancy Toxemias.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00005208 Completed - Hypertension Clinical Trials

Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension

Start date: September 1987
Phase: N/A
Study type: Observational

To elucidate the role of an imbalance in vasodilator prostacyclin (PGI2) and vasoconstrictor thromboxane (TxA2) in pregnancy-induced hypertension

NCT ID: NCT00005207 Completed - Hypertension Clinical Trials

Renin and Prorenin in Pregnancy

Start date: September 1987
Phase: N/A
Study type: Observational

To determine the role of the prorenin-renin-angiotensin-aldosterone system (RAAS) in normal and hypertensive pregnancy.

NCT ID: NCT00000543 Completed - Hypertension Clinical Trials

Oral Calcium in Pregnant Women With Hypertension

Start date: August 1993
Phase: Phase 2
Study type: Interventional

To determine of providing calcium supplementation to women with pre-existing hypertension reduces the level of blood pressure, requirement for antihypertensive drugs, and incidence of pre-eclampsia.

NCT ID: NCT00000534 Completed - Hypertension Clinical Trials

Calcium for Pre-Eclampsia Prevention (CPEP)

Start date: March 1991
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of 2 grams per day of oral calcium supplementation in reducing the combined incidence of hypertensive disorders of pregnancy: pre-eclampsia, eclampsia, and the HELLP Syndrome (hypertension, thrombocytopenia, hemolysis, and abnormal liver function). The National Institute of Child Health and Human Development (NICHD) initiated the trial in 1991, with joint funding provided by the National Heart, Lung, and Blood Institute in fiscal years 1992, 1993, and 1995.